BIOTRONIK Blog Explore our latest insightful interviews and articles Image Blog Stories Filter and Search Filter by year - Any -20252024202320222021 Search 51 blog articles Image June 7, 2022 Blog Radiation and Occupational Safety in Interventional Cardiology Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety. Image June 3, 2022 Blog The Effects of Air Pollution on Heart Health Higher quality of life, more biodiversity and a better climate – the advantages of green cities seem obvious. Green living – including breathing clean air – plays an especially crucial role for our heart health and overall well-being. On the occasion of World Environment Day, we looked at what effect air pollution has on heart health and what each of us can do to make our cities more livable. Image May 12, 2022 Blog The Role of Cardiac Nurses in the Digital Health Era Why Innovative Treatment Solutions Should Be Designed With the Nurse in Mind Image April 26, 2022 Blog How to Select ICDs and Foster Early Detection of Atrial Fibrillation The incidence of atrial fibrillation (AF) in patients with implantable cardioverter-defibrillators (ICDs) is approximately 21 percent (mean annual probability) 1 and is often undetected – and therefore untreated. Image April 6, 2022 Blog Staying Active and Sticking to Goals With a Heart Implant Cardiac pacemaker implantations are now routine interventions. Around three million people worldwide have a pacemaker, and every year 600,000 more receive an implant. Nevertheless, the diagnosis and procedure can look challenging for patients at first— especially patients who are athletes or enjoy being active. Image March 4, 2022 Blog Supporting Cardiac Device Patients in Getting MRI Scans—How Should Physicians Facilitate? More than ten years after BIOTRONIK received approval for its first ProMRI pacemaker, allowing the first cardiac device patients access to MRI scans, we still get many questions from patients about what documents they should bring to a scanning appointment—to ensure their radiologist doesn’t turn them away. Image February 11, 2022 Blog Why We Support More Representative Trials in Cardiology Cardiovascular research has achieved a lot in the last few decades—but even today the cardiology community is discussing whether the field needs gender-specific guidelines for treating cardiovascular diseases. One of the biggest obstacles is one of the most common problems in scientific research—a simple lack of data. Image January 28, 2022 Blog How Strong Data Protection Can Help Drive Digital Health Advancements It’s hard to think of information that feels more personal than data about our own health. Yet we’re generating and monitoring more health data now than ever before. Whether it’s specific technology designed to help manage certain medical conditions—such as BIOTRONIK’s Patient App or remote care with Home Monitoring—or the plethora of more general, consumer-grade wearables and health apps, there are more and more digital options to help manage patient health. Image January 5, 2022 Blog Resolutions Worth Keeping: Living Heart-Healthy in 2022 An American survey last year found that health-related goals topped the priority list of New Year’s resolutions for 2021. Around half of those surveyed wanted to exercise more or lose weight, while about 40 percent wanted to improve their diets and 10 percent wanted to quit smoking. Of those people who make resolutions, many say they do, in fact, keep them. Around half of respondents in one such survey said they kept at least some of their 2020 resolutions. About 35 percent said they met all of their goals and just 16 percent say they didn’t keep any of their resolutions. Pagination Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Previous page ‹ Previous Next page Next › Subscribe for our News You must have JavaScript enabled to use this form. Title Select TitleMsMrMXDrProf First name Last name Role Please select your roleHealthcare ProfessionalPatient or RelativeJournalistOther Email Phone Country/Region - Select -AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSarkSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkmenistanTurks & Caicos IslandsTuvaluTürkiyeU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Topic Please select a topicProductsPatientsHealthcare Professionals I prefer to be contacted by Phone Email Message *Fields are mandatory. Latest Press Releases Show all press releases Image June 4, 2025 BUELACH, Switzerland Press Release First Patient Enrolled in Leave Nothing Behind-Trial Comparing Drug-Coated Balloon-Based Strategy to Drug-Eluting Stents in Chronic Total Occlusion Patients Today BIOTRONIK announces the enrollment of the first patient in the Leave Nothing Behind-Trial. The first implantation was performed by Dr. Mohamed Ayoub at the Heart and Diabetes Center North Rhine-Westphalia, Germany. The trial aims to demonstrate the non-inferiority of drug-coated balloons (DCB) or DCBs in combination with Resorbable Magnesium Scaffolds (RMS) compared to drug-eluting stents (DES) in chronic total occlusions (CTO) in percutaneous coronary interventions (PCI). The prospective, single-center, single-blind, randomized trial evaluates the efficacy of the Pantera ® Lux ® DCB and Image May 21, 2025 PARIS, France Press Release BIOMAG-I Data Shows No New Events between Two and Three Years in Target Lesion Failure with Freesolve Resorbable Magnesium Scaffold New results from the BIOMAG-I first-in-human trial demonstrated an excellent safety and efficacy profile for Freesolve ®, BIOTRONIK’s third-generation resorbable magnesium scaffold (RMS) at three years follow-up. Prof. Dr. Michael Haude presented these new data at the EuroPCR 2025 conference in Paris. At the 36-month follow-up, the target lesion failure (TLF) rate remained at 3.5%, consisting of four cases of clinically driven target lesion revascularization (CD-TLR), of which only one event occurred beyond the resorption period of the scaffold. No cases of target-vessel myocardial infarction Image February 27, 2025 BERLIN, Germany BIOTRONIK Driving the Future of Active Device Business BIOTRONIK Driving the Future of Active Device Business BIOTRONIK, a global leader in medical technology, and a pioneer in cardiovascular, endovascular, and neuromodulation solutions, today announced a strategic shift to strengthen its leadership in active implantable devices and digital healthcare. Leveraging future technologies, including artificial intelligence (AI), remote patient monitoring and connected healthcare platforms, BIOTRONIK is at the forefront of improving patient outcomes and optimizing clinical workflows. These innovations are designed to enhance the efficiency and accessibility of care, enabling healthcare providers with next Press Contact Corporate Public Relations & Communications press@biotronik.com +49 (0) 30 68905 1414 Get in contact
Image June 7, 2022 Blog Radiation and Occupational Safety in Interventional Cardiology Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety.
Image June 7, 2022 Blog Radiation and Occupational Safety in Interventional Cardiology Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety.
Image June 3, 2022 Blog The Effects of Air Pollution on Heart Health Higher quality of life, more biodiversity and a better climate – the advantages of green cities seem obvious. Green living – including breathing clean air – plays an especially crucial role for our heart health and overall well-being. On the occasion of World Environment Day, we looked at what effect air pollution has on heart health and what each of us can do to make our cities more livable.
Image June 3, 2022 Blog The Effects of Air Pollution on Heart Health Higher quality of life, more biodiversity and a better climate – the advantages of green cities seem obvious. Green living – including breathing clean air – plays an especially crucial role for our heart health and overall well-being. On the occasion of World Environment Day, we looked at what effect air pollution has on heart health and what each of us can do to make our cities more livable.
Image May 12, 2022 Blog The Role of Cardiac Nurses in the Digital Health Era Why Innovative Treatment Solutions Should Be Designed With the Nurse in Mind
Image May 12, 2022 Blog The Role of Cardiac Nurses in the Digital Health Era Why Innovative Treatment Solutions Should Be Designed With the Nurse in Mind
Image April 26, 2022 Blog How to Select ICDs and Foster Early Detection of Atrial Fibrillation The incidence of atrial fibrillation (AF) in patients with implantable cardioverter-defibrillators (ICDs) is approximately 21 percent (mean annual probability) 1 and is often undetected – and therefore untreated.
Image April 26, 2022 Blog How to Select ICDs and Foster Early Detection of Atrial Fibrillation The incidence of atrial fibrillation (AF) in patients with implantable cardioverter-defibrillators (ICDs) is approximately 21 percent (mean annual probability) 1 and is often undetected – and therefore untreated.
Image April 6, 2022 Blog Staying Active and Sticking to Goals With a Heart Implant Cardiac pacemaker implantations are now routine interventions. Around three million people worldwide have a pacemaker, and every year 600,000 more receive an implant. Nevertheless, the diagnosis and procedure can look challenging for patients at first— especially patients who are athletes or enjoy being active.
Image April 6, 2022 Blog Staying Active and Sticking to Goals With a Heart Implant Cardiac pacemaker implantations are now routine interventions. Around three million people worldwide have a pacemaker, and every year 600,000 more receive an implant. Nevertheless, the diagnosis and procedure can look challenging for patients at first— especially patients who are athletes or enjoy being active.
Image March 4, 2022 Blog Supporting Cardiac Device Patients in Getting MRI Scans—How Should Physicians Facilitate? More than ten years after BIOTRONIK received approval for its first ProMRI pacemaker, allowing the first cardiac device patients access to MRI scans, we still get many questions from patients about what documents they should bring to a scanning appointment—to ensure their radiologist doesn’t turn them away.
Image March 4, 2022 Blog Supporting Cardiac Device Patients in Getting MRI Scans—How Should Physicians Facilitate? More than ten years after BIOTRONIK received approval for its first ProMRI pacemaker, allowing the first cardiac device patients access to MRI scans, we still get many questions from patients about what documents they should bring to a scanning appointment—to ensure their radiologist doesn’t turn them away.
Image February 11, 2022 Blog Why We Support More Representative Trials in Cardiology Cardiovascular research has achieved a lot in the last few decades—but even today the cardiology community is discussing whether the field needs gender-specific guidelines for treating cardiovascular diseases. One of the biggest obstacles is one of the most common problems in scientific research—a simple lack of data.
Image February 11, 2022 Blog Why We Support More Representative Trials in Cardiology Cardiovascular research has achieved a lot in the last few decades—but even today the cardiology community is discussing whether the field needs gender-specific guidelines for treating cardiovascular diseases. One of the biggest obstacles is one of the most common problems in scientific research—a simple lack of data.
Image January 28, 2022 Blog How Strong Data Protection Can Help Drive Digital Health Advancements It’s hard to think of information that feels more personal than data about our own health. Yet we’re generating and monitoring more health data now than ever before. Whether it’s specific technology designed to help manage certain medical conditions—such as BIOTRONIK’s Patient App or remote care with Home Monitoring—or the plethora of more general, consumer-grade wearables and health apps, there are more and more digital options to help manage patient health.
Image January 28, 2022 Blog How Strong Data Protection Can Help Drive Digital Health Advancements It’s hard to think of information that feels more personal than data about our own health. Yet we’re generating and monitoring more health data now than ever before. Whether it’s specific technology designed to help manage certain medical conditions—such as BIOTRONIK’s Patient App or remote care with Home Monitoring—or the plethora of more general, consumer-grade wearables and health apps, there are more and more digital options to help manage patient health.
Image January 5, 2022 Blog Resolutions Worth Keeping: Living Heart-Healthy in 2022 An American survey last year found that health-related goals topped the priority list of New Year’s resolutions for 2021. Around half of those surveyed wanted to exercise more or lose weight, while about 40 percent wanted to improve their diets and 10 percent wanted to quit smoking. Of those people who make resolutions, many say they do, in fact, keep them. Around half of respondents in one such survey said they kept at least some of their 2020 resolutions. About 35 percent said they met all of their goals and just 16 percent say they didn’t keep any of their resolutions.
Image January 5, 2022 Blog Resolutions Worth Keeping: Living Heart-Healthy in 2022 An American survey last year found that health-related goals topped the priority list of New Year’s resolutions for 2021. Around half of those surveyed wanted to exercise more or lose weight, while about 40 percent wanted to improve their diets and 10 percent wanted to quit smoking. Of those people who make resolutions, many say they do, in fact, keep them. Around half of respondents in one such survey said they kept at least some of their 2020 resolutions. About 35 percent said they met all of their goals and just 16 percent say they didn’t keep any of their resolutions.
Image June 4, 2025 BUELACH, Switzerland Press Release First Patient Enrolled in Leave Nothing Behind-Trial Comparing Drug-Coated Balloon-Based Strategy to Drug-Eluting Stents in Chronic Total Occlusion Patients Today BIOTRONIK announces the enrollment of the first patient in the Leave Nothing Behind-Trial. The first implantation was performed by Dr. Mohamed Ayoub at the Heart and Diabetes Center North Rhine-Westphalia, Germany. The trial aims to demonstrate the non-inferiority of drug-coated balloons (DCB) or DCBs in combination with Resorbable Magnesium Scaffolds (RMS) compared to drug-eluting stents (DES) in chronic total occlusions (CTO) in percutaneous coronary interventions (PCI). The prospective, single-center, single-blind, randomized trial evaluates the efficacy of the Pantera ® Lux ® DCB and
Image June 4, 2025 BUELACH, Switzerland Press Release First Patient Enrolled in Leave Nothing Behind-Trial Comparing Drug-Coated Balloon-Based Strategy to Drug-Eluting Stents in Chronic Total Occlusion Patients Today BIOTRONIK announces the enrollment of the first patient in the Leave Nothing Behind-Trial. The first implantation was performed by Dr. Mohamed Ayoub at the Heart and Diabetes Center North Rhine-Westphalia, Germany. The trial aims to demonstrate the non-inferiority of drug-coated balloons (DCB) or DCBs in combination with Resorbable Magnesium Scaffolds (RMS) compared to drug-eluting stents (DES) in chronic total occlusions (CTO) in percutaneous coronary interventions (PCI). The prospective, single-center, single-blind, randomized trial evaluates the efficacy of the Pantera ® Lux ® DCB and
Image May 21, 2025 PARIS, France Press Release BIOMAG-I Data Shows No New Events between Two and Three Years in Target Lesion Failure with Freesolve Resorbable Magnesium Scaffold New results from the BIOMAG-I first-in-human trial demonstrated an excellent safety and efficacy profile for Freesolve ®, BIOTRONIK’s third-generation resorbable magnesium scaffold (RMS) at three years follow-up. Prof. Dr. Michael Haude presented these new data at the EuroPCR 2025 conference in Paris. At the 36-month follow-up, the target lesion failure (TLF) rate remained at 3.5%, consisting of four cases of clinically driven target lesion revascularization (CD-TLR), of which only one event occurred beyond the resorption period of the scaffold. No cases of target-vessel myocardial infarction
Image May 21, 2025 PARIS, France Press Release BIOMAG-I Data Shows No New Events between Two and Three Years in Target Lesion Failure with Freesolve Resorbable Magnesium Scaffold New results from the BIOMAG-I first-in-human trial demonstrated an excellent safety and efficacy profile for Freesolve ®, BIOTRONIK’s third-generation resorbable magnesium scaffold (RMS) at three years follow-up. Prof. Dr. Michael Haude presented these new data at the EuroPCR 2025 conference in Paris. At the 36-month follow-up, the target lesion failure (TLF) rate remained at 3.5%, consisting of four cases of clinically driven target lesion revascularization (CD-TLR), of which only one event occurred beyond the resorption period of the scaffold. No cases of target-vessel myocardial infarction
Image February 27, 2025 BERLIN, Germany BIOTRONIK Driving the Future of Active Device Business BIOTRONIK Driving the Future of Active Device Business BIOTRONIK, a global leader in medical technology, and a pioneer in cardiovascular, endovascular, and neuromodulation solutions, today announced a strategic shift to strengthen its leadership in active implantable devices and digital healthcare. Leveraging future technologies, including artificial intelligence (AI), remote patient monitoring and connected healthcare platforms, BIOTRONIK is at the forefront of improving patient outcomes and optimizing clinical workflows. These innovations are designed to enhance the efficiency and accessibility of care, enabling healthcare providers with next
Image February 27, 2025 BERLIN, Germany BIOTRONIK Driving the Future of Active Device Business BIOTRONIK Driving the Future of Active Device Business BIOTRONIK, a global leader in medical technology, and a pioneer in cardiovascular, endovascular, and neuromodulation solutions, today announced a strategic shift to strengthen its leadership in active implantable devices and digital healthcare. Leveraging future technologies, including artificial intelligence (AI), remote patient monitoring and connected healthcare platforms, BIOTRONIK is at the forefront of improving patient outcomes and optimizing clinical workflows. These innovations are designed to enhance the efficiency and accessibility of care, enabling healthcare providers with next